Mathew Blackman
Stock Analyst at TD Cowen
(3.13)
# 1,147
Out of 5,157 analysts
67
Total ratings
53.19%
Success rate
11.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SIBN SI-BONE | Maintains: Buy | $21 → $22 | $13.82 | +59.19% | 2 | Feb 24, 2026 | |
| OFIX Orthofix Medical | Initiates: Hold | $14 | $12.37 | +13.18% | 6 | Jan 27, 2026 | |
| KIDS OrthoPediatrics | Initiates: Buy | $23 | $17.81 | +29.14% | 1 | Jan 27, 2026 | |
| BBNX Beta Bionics | Initiates: Hold | $17 | $10.97 | +54.97% | 2 | Jan 27, 2026 | |
| ISRG Intuitive Surgical | Initiates: Buy | $660 | $485.85 | +35.84% | 1 | Jan 27, 2026 | |
| INGN Inogen | Maintains: Hold | $10 → $7 | $6.22 | +12.54% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $21.88 | +41.68% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $336.74 | -5.57% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $11.32 | +120.85% | 3 | Apr 1, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $238.24 | +22.99% | 5 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $94 | $86.65 | +8.48% | 5 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $3 | $1.77 | +69.49% | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $100 | $67.79 | +47.51% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $12.51 | +27.90% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.70 | +13.40% | 4 | May 10, 2023 |
SI-BONE
Feb 24, 2026
Maintains: Buy
Price Target: $21 → $22
Current: $13.82
Upside: +59.19%
Orthofix Medical
Jan 27, 2026
Initiates: Hold
Price Target: $14
Current: $12.37
Upside: +13.18%
OrthoPediatrics
Jan 27, 2026
Initiates: Buy
Price Target: $23
Current: $17.81
Upside: +29.14%
Beta Bionics
Jan 27, 2026
Initiates: Hold
Price Target: $17
Current: $10.97
Upside: +54.97%
Intuitive Surgical
Jan 27, 2026
Initiates: Buy
Price Target: $660
Current: $485.85
Upside: +35.84%
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $6.22
Upside: +12.54%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $21.88
Upside: +41.68%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $336.74
Upside: -5.57%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $11.32
Upside: +120.85%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $238.24
Upside: +22.99%
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $86.65
Upside: +8.48%
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.77
Upside: +69.49%
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $67.79
Upside: +47.51%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $12.51
Upside: +27.90%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.70
Upside: +13.40%